Dr. Denise Faustman

Patient Leader

Denise Faustman, MD, PhD, is Director of the Immunobiology Laboratory at the Massachusetts General Hospital (MGH) and an Associate Professor of Medicine at Harvard Medical School. Her current research focuses on discovering and developing new treatments for type 1 diabetes and other autoimmune diseases. She is currently leading a human clinical trial program that is testing the efficacy of the BCG vaccine--better known for its use in tuberculosis prevention--for a new use: the reversal of long-term type 1 diabetes. The BCG vaccine is a safe, relatively inexpensive, generic drug that may be a low-cost option for improving type 1 diabetes for the many people who have been living with this disease for years. In a Phase I clinical trial, the drug temporarily restored insulin production in patients who had type 1 diabetes for an average of 15 years. A Phase II human clinical trial is currently being planned.

Past Awards Participation

Third Annual Health Activist Awards

Nominations

Best Kept Secret Geek Health Activist Health Activist Hero
Dr. Denise Faustman

You Might Also Like

Yvonne Desousa

Hilarious Health Activist Nominee

Hilarious Patient Leader Nominee

Kristin Selby Gonzalez

Advocating For Another Nominee

Best in Show: Community Nominee

Dawn Lyons

Best in Show: Community Nominee

Julie Rauch

Best in Show: Facebook Nominee

Advocating for Another Nominee

Tayla Holman

Patient Leader Hero Nominee

Aimee Wilson

Best in Show: Blog Nominee

Best in Show: Blog Nominee